[HTML][HTML] A summary of worldwide national activities in chronic kidney disease (CKD) testing

R Ruiz-Arenas, R Sierra-Amor, D Seccombe… - Ejifcc, 2017 - ncbi.nlm.nih.gov
Chronic kidney disease (CKD) is a major public health issue worldwide and is associated
with adverse health outcomes, especially in low-and middle-income countries. In a cash …

Role of Cystatin C and glomerular filtration rate in diagnosis of kidney impairment in hepatic cirrhosis patients

D Wang, JF Feng, AQ Wang, YW Yang, YS Liu - Medicine, 2017 - journals.lww.com
Hepatic cirrhosis is often accompanied by functional kidney impairment, which may be
reversed if early treatment is promptly administered. This study aimed to investigate the role …

血清胱抑素C 及其估算肾小球滤过率在亚临床肝肾综合征诊断中的应用.

何流, 陈世银, 陈志富, 杨发成… - Progress in Modern …, 2016 - search.ebscohost.com
摘要目的: 探讨血清胱抑素C (CysC) 及其估算肾小球滤过率(eGFR) 在肝肾综合征(HRS)
诊断中的应用价值. 方法: 测定218 例肝硬化腹水患者的血清CysC 和肌酐(Cr) 浓度, 并采用CKD …

Identifying the pattern and risk factors for potential medication dosing errors in chronic renal impairment of critically ill patients

B Sedaghat, S Abbasi, S Farsaei - Trends in Pharmaceutical …, 2021 - tips.sums.ac.ir
Purpose: Different prescription entries usually complicate the drug therapy for critically ill
patients; therefore, we conducted this prospective study to assess the rates for appropriate …

Trends in Arteriovenous Fistula Use at Dialysis Initiation After Automated eGFR Reporting

MM Sood, A Akbari, B Hiebert, S Hiremath… - Seminars in …, 2015 - Wiley Online Library
The purpose of this study was to examine trends in the presence of an arteriovenous fistula
(AVF) at dialysis initiation before and after eGFR reporting. All incident dialysis patients from …

[引用][C] 胱抑素C 及其eGFR 方程在诊断肝硬化患者肾损害中的应用

杨渝伟, 黄玉霞, 陈小红, 俸家富 - 现代检验医学杂志, 2016

[引用][C] 胱抑素C 及其eGFR 方程在诊断肝硬化患者肾损害中的应用

黄玉霞, 杨渝伟, 邹明, 池继敏, 俸家富 - 四川医学, 2015

[引用][C] 2 型糖尿病伴微量白蛋白尿患者血清B 型脑钠肽与肾功能的相关性研究

李春北, 周莉娟, 张燕燕, 张启谊, 徐书涛 - 医学临床研究, 2013